Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Offers Jobs Courses Forums Movies Games
Sign In Sign Up
Night Mode
Novel Non-Hormonal Neurokinin Receptor Antagonists Transforming Vasomotor Symptom Relief
The development and commercial launch of non-hormonal neurokinin-3 (NK3) receptor antagonists represent a landmark therapeutic breakthrough for menopausal symptom management. Detailed analysis within the Menopause Treatment Market report highlights how selective NK3 receptor antagonists target the KNDy (kisspeptin/neurokinin B/dynorphin) neuronal network in the hypothalamus directly. Blocking...
0 Comments ·0 Shares ·6 Views ·0 Reviews
Please log in to like, share and comment!